# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Industry leading product available through Twist ecommerce platformTwist Gene Fragments now available up to 5.0kb in length wit...
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $6...
JP Morgan analyst Tycho Peterson maintains Twist Bioscience (NASDAQ:TWST) with a Underweight and raises the price target fro...
Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthe...
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $...
https://x.com/ScorpionFund/status/1819408275474874573
Twist Bioscience reported a Q3 adjusted EPS loss of $(0.70), surpassing the $(0.77) consensus. With a net loss of $85.6 million...